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ABSTRACT
Purpose: To detect circulating retina-specific autoreactive CD4+ T-cells and antiretinal antibodies (ARA)
in latent tuberculosis (TB)-associated uveitis or sarcoid uveitis patients.
Methods: The presence of crude retinal extract (RE) autoreactive CD4+ T-cells was determined by
a highly sensitive flowcytometric-based technique examining co-expression of CD25 and CD134
(OX40) on RE stimulated PBMC. The presence of ARA in available matched serum samples was assessed
by indirect immunofluorescence.
Results: No autoreactive CD4+ T-cells against RE could be detected in either latent TB-associated uveitis
or sarcoid uveitis patients, while ARA were detected in the serum of the majority (5/6) of latent TB-
associated uveitis and all (3/3) sarcoid uveitis patients.
Conclusion: Even with the use of this highly sensitive flowcytometric technique circulating retina-
specific autoreactive CD4+ T-cells could not be detected. In contrast, ARA were detected in the majority
of patients indicating an adaptive humoral immune response toward retinal antigens had occurred.
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Tuberculosis (TB)-associated uveitis represents a major cause
of uveitis, particularly in TB endemic countries. The patho-
physiology of TB-associated uveitis is still incompletely
understood. Ocular infection with Mycobacterium tuberculosis
(Mtb) is a very rare condition that may cause uveitis when
Mtb-bacilli invade the eye and consequently elicit local gran-
ulomatous inflammation.1–3 In support of local ocular infec-
tion by Mtb, anti-tuberculosis therapy (ATT) can be very
effective in TB-associated uveitis patients without systemic
signs of TB, higher response rates have been witnessed in
patients with a high QuantiFERON-TB Gold test (QFT)
score.4 However, the results were often inconclusive, better
responses to ATT in combination with corticosteroids have
been shown and a significant number of patients still need
corticosteroid treatment after ATT, which may point to the
involvement of other pathophysiological mechanisms as well.
Several lines of evidence suggest that autoimmune reactions
against retinal antigens might constitute part of the patho-
physiology of uveitis, which may especially be relevant in the
setting of latent TB-associated uveitis.4–8
Autoreactive T-cells toward crude retinal extract (RE) have
been found in vitreous samples from patients with TB-
associated uveitis.9 Yet, this study failed to identify RE auto-
reactive T-cells in paired peripheral blood samples, which was
attributed to a presumed low-frequency of RE-specific T-cells
in peripheral blood.9 Alternatively, the sensitivity of the
experimental approach (intracellular cytokine staining)
might impede detection in this study.9 Detection of peripheral
T-cells with auto-reactivity toward retinal antigens is, how-
ever, necessary for a good understanding of the immuno-
pathogenesis of TB-associated uveitis and subsequent
treatment and thus warrants further study.9
To detect retina-specific autoreactive T-cells in peripheral
blood, we retrospectively examined induction of the activation
markers CD25 (IL-2 Receptor-α) and CD134 (OX40) on the
cell surface of CD4+ T-cells of patients with latent TB-
associated uveitis upon stimulation with RE. This approach
displays higher sensitivity than other techniques used to
detect antigen-specific T-cell activation, including intracellu-
lar cytokine detection.10,11 The potential of this test has been
shown for detecting latent TB infections by measuring specific
T-cell recall responses to Mtb-specific peptides.12 Therefore,
stimulation experiments with Mtb purified protein derivative
(PPD) served as a control in our study. Antiretinal autoanti-
bodies (ARA) were previously found in TB-associated
uveitis.13 As the initiation of a humoral immune response
may depend on T-cell help, we measured ARA in available
paired serum samples. Outcomes of latent TB-associated uvei-
tis patients were compared to those from patients with sarcoid
uveitis as this disease shares multiple immunopathological
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features with TB and is sometimes clinically hard to distin-
guish from latent TB-associated uveitis.8,14,15
Material and Methods
Patients and Sample Collection
In this study, patients with latent TB-associated uveitis (n = 7)
and sarcoid uveitis (n = 4) who visited the outpatient clinic of
the department of Ophthalmology and Clinical Immunology
of the Erasmus MC, University Medical Center, Rotterdam
were included. All patients underwent a standardized uveitis
work-up and full ophthalmological examination.16 In patients
with anterior uveitis and panuveitis, the human leukocyte
antigen (HLA) B27 was determined. Patient characteristics
are given in supplementary Table 1.
Diagnosis of latent TB-associated uveitis was assigned after
the exclusion of underlying systemic diseases and other causes
of uveitis, a positive score (>0,35 IU/ml) in the QFT, and the
absence of any signs suggesting active TB. The diagnosis of
definite sarcoid uveitis was given after excluding other causes
of uveitis and conformation by biopsy of an accessible inflam-
mation site. Sarcoidosis patients included were QFT negative.
Blood samples were collected and peripheral blood mono-
nuclear cells (PBMC) were isolated using a Ficoll (GE health-
care, Chicago, IL, USA) based density separation technique.
Subsequently, PBMC were frozen until further analysis.
Demographic data were collected at the time of sampling.
All subjects provided their written informed consent. The
study was approved by the medical ethical committee of the
Erasmus MC, University Medical Center, Rotterdam (proto-
col number MEC-2016-606) and in coherence with the tenets
of the Declaration of Helsinki.
Retinal Extracts
Retina extract was prepared as described previously by Kuiper
et al.17 In brief, retina tissue was obtained from a postmortem
eye without a history of intraocular inflammation or vitreor-
etinal disease. The retina was carefully dissected from the
underlying pigment epithelium, homogenized in 500 µL phos-
phate-buffered saline (PBS) and subsequently centrifuged
(10000 relative centrifugal force (RCF), 4°C, 30 min). The
supernatant was carefully collected and heat-inactivated at
100°C for 7 min to neutralize endogenous tissue protease
activity. Protein yield was assessed by colorimetric Bradford
assay and the extract was aliquoted and stored at −80°C until
further use.
Human Umbilical Vein Endothelial Cell Extracts
The human umbilical vein endothelial cell line (HUVEC) was
cultured in the EBMTM-2 basal medium supplemented with
EGMTM-2 SingleQuatsTM (Lonza, Basel, Switzerland) and
penicillin and streptomycin (100 IU/ml; BioWhittaker,
Verviers, Belgium). Cells were harvested by scraping, homo-
genized in 500 µL PBS containing the protease inhibitors
prefabloc (Roche, Basel, Switzerland), α-prot (Roche), and
sodium orthovanadate (Sigma-Aldrich, St. Louis, MO, USA),
followed by three cycles of freeze-thawing and subsequently
centrifuged (10000 RCF, 4°C, 30 min). The supernatant was
carefully collected, protein yield was assessed by colorimetric
Bradford assay and the extract was aliquoted and stored at
−80°C until further use.
Detection of Antigen-Specific CD4+ T-Cells by
Measurement of CD25/CD134 Co-Expression
Cryopreserved PBMC were thawed and suspended in RPMI-
1640 (Gibco, Paisley, UK) culture medium supplemented with
10% fetal calf serum (Gibco), L-glutamine 2 mM
(BioWhittaker), and penicillin and streptomycin (100 IU/ml;
BioWhittaker). Cells were seeded onto 24-well plates, at 0.5 ×
106 cells per well. For each assay, the following conditions
were used: no exogenous stimulation (negative control), sti-
mulation with 2,5 µg/ml phytohemagglutinin (PHA; positive
control), RE or HUVEC protein lysate (irrelevant protein
control) at final concentrations of 100-, 10-, or 1 µg/ml. As
an antigen-specific positive control for the latent TB-
associated uveitis patients, PBMC were stimulated with myco-
bacterium tuberculosis PPD (Statens Serum Institute,
Copenhagen, Denmark) at a concentration of 4 µg/ml. Cells
were stimulated for 48 h in a humidified 5% CO2 incubator.
Subsequently, 100 µl of cell suspension of each culture was
stained for 15 min at room temperature (RT) with 20 μl of the
antibody mixture provided in the Act-T4 CellTM kit (CD3-
PerCP-Cy5.5, CD4-FITC, CD25-APC, and CD134-PE;
Cytognos, Salamanca, Spain), for better selection of the leu-
kocyte population, 5 μl CD45-PO (Invitrogen Corporation,
Carlsbad, CA, USA) was added to the antibody mix.
Thereafter, erythrocytes were lysed with erythrocyte lyse-non-
wash solution provided in the Act-T4 CellTM kit following the
manufactures instructions. Cells were measured using a BD
FACSCantoTM (BD Biosciences, San Jose, CA, USA) cell ana-
lyzer. Flow-cytometric data were analyzed using the Infinicyt
software (Cytognos).
Leukocytes were selected by CD45 vs side scatter, after
which T-lymphocytes were identified using a CD3 vs side
scatter gate, followed by a selection of CD3+CD4+ T-cells,
which were then analyzed for CD25 and CD134 co-
expression. Gates for CD25+ and CD134+ were based upon
a comparison of negative control (unstimulated) and positive
control (PHA) stimulation. Results for induction of
CD3+CD4+CD25+CD134+ T-cells obtained upon stimulation
with RE, HUVEC lysate or mycobacterium tuberculosis PPD
were calculated as a stimulation index relative to maximal
induction obtained with PHA (specific stimulus/PHA
stimulus).
Detection of Antiretinal Antibodies by Indirect
Immunofluorescence (IIF)
Serum ARA were determined as described previously.16 In
short, primate retinal tissue (EuroImmun, Lubeck,
Germany) was incubated with patients' serum (1:100 dilu-
tion) for 30 min at RT. After washing with PBS 0.2%
Tween, sections were incubated with goat anti-human
IgA/G/M conjugated with fluorescein isothiocyanate
2 B. SCHRIJVER ET AL.
(EuroImmun) for 30 min at RT. Sections were washed with
PBS 0.2% Tween, embedded in glycerol and covered with
a coverslip. Slides were analyzed using an AXIO Lab.A1
fluorescence microscope (Zeiss, Thornwood, NY, USA) and
photographed at 200x and 400x magnification using
a Nikon DS-Fi1 camera (Minato, Tokyo, Japan). Retinal
tissue incubated with PBS or 1:100 diluted serum from
a person negative for anti-nuclear antibodies (ANA) and
ARA were used as negative controls. As positive controls,
retinal tissue was incubated with either 1:100 diluted serum
from an ANA positive person or 1:100 diluted serum from
an ARA positive person. Sera from the included patients
(1:80 dilution) were also analyzed for the presence of ANA
by IIF using HEp-2 cells (Inova, San Diego, CA, USA)
according to routine diagnostic protocols used in the
laboratory medical immunology of the department of
immunology within Erasmus MC. A positive staining of
nuclei within the retinal tissue was scored as undetermined
in case of a positive ANA result.
Statistics
All data analyses were performed in GraphPad Prism 5.0.
Comparison between two groups was performed by an
unpaired, two-tailed student's t-test. Correlations were calcu-
lated by pearson’s correlation coefficient. A p-value < .05 was
considered significant.
Results
Patients' Characteristics
The mean age of the latent TB-associated uveitis patients at
the moment of blood sampling was 47 years (range 29–66
years) and 40 (range 29–51) for the sarcoid uveitis patients.
The mean duration of uveitis was 5.5 years for the latent TB-
associated uveitis group and 1.5 years for the sarcoid uveitis
group. None of the latent TB-associated uveitis patients
received immune suppressive therapy (IST) nor ATT within
3 months before study inclusion. From the ocular sarcoidosis
patients, three did not receive IST within 3 months before
study inclusion, while in one of the patients, IST (methotrex-
ate) was started 1 month before blood drawing. For a detailed
overview of all assessed individual patient characteristics, see
supplementary Table 1.
Detection of Antigen-Specific CD4+ T-Cells
In all patients tested, stimulation of PBMC with PHA
resulted in clear activation of the CD4+ T-lymphocytes
as evidenced by an increase of the CD4+CD25+CD134+
T-lymphocyte fraction. Yet, the increase in
CD4+CD25+CD134+ T-lymphocytes was significantly (p <
0,05) lower in the latent TB-associated uveitis group than
the sarcoid uveitis group (Figures 1 and 2a). Moreover, in
the latent TB-associated uveitis group the responsiveness
of CD4+ T-lymphocytes to PHA correlated significantly
Figure 1. Representative flowcytometric analysis of peripheral blood mononuclear cells (PBMC) from a latent tuberculosis-associated uveitis (L-TBU) and sarcoid
uveitis (SU) patient, unstimulated (left column) and stimulated with 2.5µg/ml phytohemagglutinin (PHA; right column).
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(p < .05, r2 = 0.63) with the observed response upon
mycobacterium tuberculosis PPD stimulation (Figure 2b).
Six out of seven latent TB-associated uveitis patients
responded to mycobacterium tuberculosis PPD stimula-
tion with an induction of CD4+CD25+CD134+ population
with a stimulation index of at least 0.05. This mycobacter-
ium tuberculosis PPD stimulation index did not exceed
0.03 in the sarcoid uveitis group (Figure 3). Stimulation
with the different RE concentrations seemed to have
a slight stimulatory effect on T-cells from 3 out of 7 latent
TB-associated uveitis patients (Figure 4a). Yet the same
patients also responded to stimulation with HUVEC pro-
tein lysate, which served as irrelevant protein control
(Figure 4b). Therefore, the T-cell responses observed to
RE in these patients were considered a-specific.
Detection of Serum ARA
Serum for detection of ARA was available from six of the
latent TB-associated uveitis patients and from three of the
sarcoid uveitis patients. Five of the six latent TB-associated
uveitis patients' sera revealed reactivity against retinal tissue.
In one of these cases, positivity against retinal cell nuclei was
observed in combination with ANA positivity and was there-
fore scored as undetermined. The other four positive latent
TB-associated uveitis cases displayed reactivity of varying
intensity (weak to strong) against retinal cell nuclei and/or
the photoreceptor layer and the outer limiting membrane
(OLM; Figure 5) and were ANA negative. Sera of all three
sarcoid uveitis patients were ANA negative but did display
reactivity against retinal cell nuclei with two sera also display-
ing reactivity against the photoreceptor layer and one also
against the OLM. Retinal staining patterns are summarized
in Table 1.
Discussion
In this study, we used a sensitive flowcytometry-based assay to
detect retina-autoreactive CD4+ T-cell responses. Yet, no
retina-autoreactive CD4+ T-cells were found in peripheral
blood of patients with latent TB-associated uveitis or sarcoid
uveitis. In contrast, specific ARA were detected in the major-
ity of latent TB-associated uveitis and sarcoid uveitis patients.
Retinal autoimmunity has been proposed in TB-associated
uveitis for a while.18,19 Moreover, the development of anterior
granulomatous uveitis has been described following Bacille-
Calmette-Guérin (BCG) therapy for bladder carcinoma. This
was associated with the presence of peripheral T-cells that
proliferated and produced cytokines (a.o. T-helper 1 (Th1)
cytokines like IFN-γ and TNF-α) upon exposure to mycobac-
terium tuberculosis PPD as well as specific retinal antigens.7
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Figure 2. (a) Percentage CD25+ CD134+ of CD4+ T-cells after PBMC from L-TBU (n = 7) or SU (n = 4) were cultured for 48 h in the presence (black squares) or absence
(gray circles) of 2.5 µg/ml PHA. Each circle and related square represent an individual patient. Horizontal lines indicate the mean values. Statistical analysis was done
using the unpaired, two-tailed student's t-test. * = P < .05. (b) Correlation between the percentages of CD25+ CD134+ CD4+ T-cells observed in L-TBU patients after
PBMC stimulation with either 4 µg/ml mycobacterium tuberculosis purified protein derivative (PPD) or 2.5 µg/ml PHA. Statistical analysis was done using the
spearman’s rank correlation test.
Figure 3. T-cell response to mycobacterium tuberculosis PPD stimulation. Each
circle represents an individual patient (L-TBU n = 7, SU n = 4). Data are
represented as a CD25+ CD134+ stimulation index (effect specific stimulus/effect
PHA stimulus).
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The fact that retina-specific CD4+ T-cells could not be
detected in our study is unlikely to be related to
a generalized state of unresponsiveness, as PBMC from all
patients responded to PHA stimulation and PBMC from 6 out
of 7 latent TB-associated uveitis cases also responded to
mycobacterium tuberculosis PPD stimulation. In addition,
IFN-γ was detected in the culture supernatant of 3 out of 7
latent TB-associated uveitis cases after stimulation with PPD
(data not shown). We can however not exclude the possibility
that our RE isolation procedure resulted in the generation of
heat-denatured proteins that might not be easily processed by
antigen-presenting cells and subsequently presented to
T-lymphocytes. The PHA response was however significantly
lower in the latent TB-associated uveitis group, suggesting
a certain level of T-cell unresponsiveness or exhaustion in
comparison to sarcoid uveitis patients, even though a-specific
and pathogen specific recall responses have been shown to be
reduced in sarcoidosis patients.20 This is further supported by
the positive correlation between the mycobacterium tubercu-
losis PPD induced response and the PHA induced response
observed in the latent TB-associated uveitis group.
There are several possibilities why retina-autoreactive CD4+
T-cells were not detected in the patient’s blood samples. First, the
number of circulating retina-autoreactive CD4+ T-cells might be
extremely low in the blood of latent TB-associated uveitis
patients and therefore too low for detection. This was also
suggested by Tagirasa et al. who did find autoreactive T-cells
toward RE in vitreous samples from TB-associated uveitis
patients but not in matched peripheral blood samples.9 Second,
uveitis activity and limited patient inclusion might have con-
tributed to our findings. In this study, only three out of the seven
latent TB-associated uveitis and two out of the four sarcoid
uveitis patients had active uveitis at the time of sampling. In
contrast, previous studies that did find circulating autoreactive
T-cells to specific retinal antigens or RE in patients with uveitis
(e.g. sarcoidosis, Behçet disease, Vogt-Koyanagi-Harada syn-
drome, and birdshot chorioretinopathy) mostly included
patients with active uveitis.17,21,22 Moreover, the studies that
did find circulating retina-autoreactive T-cells enrolled higher
patient numbers but detected autoreactive T-cells only in part of
the included patients.17,21,22 Lastly, for this study, we used cryo-
preserved cells which might lead to suboptimal responses to
certain stimuli in comparison to freshly isolated blood mono-
nuclear cells.23
Although autoreactive CD4+ T-cells against RE were not
detected in peripheral blood of the latent TB-associated uvei-
tis patients, we did detect serum ARA in 5/6 (83%) of these
cases. This is at a higher prevalence than our group previously
described in presumably healthy blood donors from the
Netherlands (17%),16 but also in Indonesian patients with
uveitis in the setting of active TB (44%) or latent TB
(37%).13 The three sarcoid uveitis sera analyzed were all
ARA positive (100%), indicative of an autoimmune compo-
nent in these cases as well, yet without detectable retina-
autoreactive T-cells in the peripheral blood. Serum antibodies
to retinal antigens have been previously described in ~44% of
sarcoid uveitis patients.24
Although there is no evidence that these ARA are patho-
genic and may just reflect retinal damage their presence might
support the occurrence of a T-cell dependent anti-retinal
immune response in cases of TB-associated as well as sarcoid
uveitis. Yet, we cannot exclude the possibility of a T-cell
independent humoral immune response against retina anti-
gens nor potential molecular mimicry as has been demon-
strated to exist for mycobacterial heat-shock protein-65 and
medium molecular weight neurofilament (NF-M).25,26
Discrepancies between autoantibody positivity and the
absence of detectable circulating autoreactive T-cells have
been observed in other disease entities as well, for instance
in anti-Hu antibody-associated paraneoplastic neurological
syndromes.27 The high ARA prevalence observed in our cur-
rent study might be an overestimation as the number of
patients per uveitis group was small.
In conclusion, we were unable to demonstrate circulating
autoreactive T-cells to RE in peripheral blood samples from
patients with latent TB-associated uveitis or sarcoid uveitis.
Although the absence of circulating retina-specific autoreactive
T-cells cannot be ruled out, we propose that the number of such
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Figure 4. T-cell response upon stimulation with (a) retinal extract (RE; 100-, 10-, 1 ug/ml) or (b) human umbilical vein endothelial cell (HUVEC) protein lysate (100-, 10-,
1 ug/ml) in L-TBU patients (n = 7, circles) or SU patients (n = 4, black squares). Each circle or square represents an individual patient. Data are represented as a CD25+
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cells is far too low for reliable detection, even here with the use of
highly sensitive flowcytometric approach. To determine the
presumed pathophysiological role of autoimmune reactions in
active and inactive TB-associated uveitis, as well as sarcoid
uveitis, intraocular fluid samples should be examined.
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